The effect of dexmedetomidine on motor-evoked potentials during pediatric posterior spinal fusion surgery: a retrospective case-control study.
Francesca HoltSamuel StrantzasChristian ZaarourRacha ChamlatiIan VreugdenhilIgor LuginbuehlCengiz KarsliDavid FaraoniPublished in: Canadian journal of anaesthesia = Journal canadien d'anesthesie (2020)
Dexmedetomidine at commonly used infusion rates of 0.3 µg·kg-1·hr-1 or 0.5 µg·kg-1·hr-1 causes a significant decrease in MEP amplitude during pediatric PSFS. We suggest that dexmedetomidine should be avoided in children undergoing PSFS so as not to confuse the interpretation of this important neurophysiological monitor.